Minimal Optimal Dose of Sugammadex in Elective Surgery
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2019
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 14 Feb 2019 Status changed from recruiting to completed.
- 30 Jul 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Sep 2018.
- 07 May 2018 New trial record